Amicus Therapeutics
FOLD
FOLD
289 hedge funds and large institutions have $2.88B invested in Amicus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 108 increasing their positions, 104 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.33% less ownership
Funds ownership: 104.51% → 102.18% (-2.3%)
13% less capital invested
Capital invested by funds: $3.31B → $2.88B (-$434M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
289
Holding in Top 10
4
Calls
$4.77M
Puts
$4.87M
Top Buyers
| 1 | +$47.9M | |
| 2 | +$46.8M | |
| 3 | +$34.8M | |
| 4 |
BlackRock
New York
|
+$18.7M |
| 5 |
O
OrbiMed
New York
|
+$17.8M |
Top Sellers
| 1 | -$59.3M | |
| 2 | -$39.6M | |
| 3 | -$30.6M | |
| 4 |
Morgan Stanley
New York
|
-$21.8M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$16.2M |